Transforming growth factor-β1 decreases erythropoietin production through repressing hypoxia-inducible factor 2α in erythropoietin-producing cells
Abstract Background Renal erythropoietin (EPO)-producing (REP) cells produce EPO through hypoxia-inducible factor (HIF) 2α-activated gene transcription. Insufficient EPO production leads to anemia in patients with chronic kidney disease. Although recombinant EPO is effective to improve anemia, no re...
Guardado en:
Autores principales: | Hong-Mou Shih, Szu-Yu Pan, Chih-Jen Wu, Yu-Hsiang Chou, Chun-Yuan Chen, Fan-Chi Chang, Yi-Ting Chen, Wen-Chih Chiang, Hsing-Chen Tsai, Yung-Ming Chen, Shuei-Liong Lin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4cecab6670294871beec1077d0bd73b3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Can Erythropoietin Reduce Hypoxemic Neurological Damages in Neonates With Congenital Heart Defects?
por: Sara Ottolenghi, et al.
Publicado: (2021) -
PCR assembly of synthetic human erythropoietin gene
por: Bustami,Yazmin, et al.
Publicado: (2009) -
Characteristics of erythropoietin antibodies in patients treated with recombinant human erythropoietin
por: A. M. Kudryashova, et al.
Publicado: (2020) -
The use of erythropoietins in oncology
por: Liliya E. Ziganshina, et al.
Publicado: (2021) -
EFFECT OF ERYTHROPOIETIN ON CYTOKINE PRODUCTION BY STEM CELLS
por: A. P. Lykov, et al.
Publicado: (2019)